FASENRA
NDC 0310-1830, Benralizumab, injection, solution, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-1830
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761070
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENRALIZUMAB30 mg/mL
Pharmacologic classes
Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]; Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-1830-30 | 00310183030 | 1 CARTRIDGE in 1 CARTON (0310-1830-30) / 1 mL in 1 CARTRIDGE |
| 0310-1830-85 | 00310183085 | 1 CARTRIDGE in 1 CARTON (0310-1830-85) / 1 mL in 1 CARTRIDGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/da6aca1a-19ed-44a4-abb7-696c7d58b784Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0310-1830
Use it
Look up 0310-1830 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-1830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.